BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38269635)

  • 1. How to assess the epidemiology of arrhythmogenic ventricular cardiomyopathy.
    Kataoka N; Imamura T
    Clin Cardiol; 2024 Jan; 47(1):e24203. PubMed ID: 38269635
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiomyopathies: An Overview.
    Ciarambino T; Menna G; Sansone G; Giordano M
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sudden death related cardiomyopathies - Arrhythmogenic right ventricular cardiomyopathy, arrhythmogenic cardiomyopathy, and exercise-induced cardiomyopathy.
    Goff ZD; Calkins H
    Prog Cardiovasc Dis; 2019; 62(3):217-226. PubMed ID: 31004608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of the inherited cardiomyopathies.
    McKenna WJ; Judge DP
    Nat Rev Cardiol; 2021 Jan; 18(1):22-36. PubMed ID: 32895535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of left and right bundle branch block morphology ventricular tachycardia amongst patients with arrhythmogenic cardiomyopathy and sustained ventricular tachycardia: insights from the European Survey on Arrhythmogenic Cardiomyopathy.
    Belhassen B; Laredo M; Roudijk RW; Peretto G; Zahavi G; Sen-Chowdhry S; Badenco N; Te Riele ASJM; Sala S; Duthoit G; van Tintelen JP; Paglino G; Sellal JM; Gasperetti A; Arbelo E; Andorin A; Ninni S; Rollin A; Peichl P; Waintraub X; Bosman LP; Pierre B; Nof E; Miles C; Tfelt-Hansen J; Protonotarios A; Giustetto C; Sacher F; Hermida JS; Havranek S; Calo L; Casado-Arroyo R; Conte G; Letsas KP; Zorio E; Bermúdez-Jiménez FJ; Behr ER; Beinart R; Fauchier L; Kautzner J; Maury P; Lacroix D; Probst V; Brugada J; Duru F; de Chillou C; Bella PD; Gandjbakhch E; Hauer R; Milman A
    Europace; 2022 Feb; 24(2):285-295. PubMed ID: 34491328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic Expression, Natural History, and Risk Stratification of Cardiomyopathy Caused by Filamin C Truncating Variants.
    Gigli M; Stolfo D; Graw SL; Merlo M; Gregorio C; Nee Chen S; Dal Ferro M; PaldinoMD A; De Angelis G; Brun F; Jirikowic J; Salcedo EE; Turja S; Fatkin D; Johnson R; van Tintelen JP; Te Riele ASJM; Wilde AAM; Lakdawala NK; Picard K; Miani D; Muser D; Maria Severini G; Calkins H; James CA; Murray B; Tichnell C; Parikh VN; Ashley EA; Reuter C; Song J; Judge DP; McKenna WJ; Taylor MRG; Sinagra G; Mestroni L
    Circulation; 2021 Nov; 144(20):1600-1611. PubMed ID: 34587765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of cardiomyopathies in children and adolescents: a retrospective study over the last 10 years.
    Malcić I; Jelusić M; Kniewald H; Barisić N; Jelasić D; Bozikov J
    Cardiol Young; 2002 May; 12(3):253-9. PubMed ID: 12365172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study.
    Brownrigg JR; Leo V; Rose J; Low E; Richards S; Carr-White G; Elliott PM
    Heart; 2022 Aug; 108(17):1383-1391. PubMed ID: 34969871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic accuracy of right ventriculography in arrhythmogenic right ventricular cardiomyopathy.
    Daliento L; Rizzoli G; Thiene G; Nava A; Rinuncini M; Chioin R; Dalla Volta S
    Am J Cardiol; 1990 Sep; 66(7):741-5. PubMed ID: 2399893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NA; Cooper LT; Link MS; Maron MS;
    Circulation; 2015 Dec; 132(22):e273-80. PubMed ID: 26621644
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification, Epidemiology, and Global Burden of Cardiomyopathies.
    McKenna WJ; Maron BJ; Thiene G
    Circ Res; 2017 Sep; 121(7):722-730. PubMed ID: 28912179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial screening in case of acute myocarditis reveals inherited arrhythmogenic left ventricular cardiomyopathies.
    Piriou N; Marteau L; Kyndt F; Serfaty JM; Toquet C; Le Gloan L; Warin-Fresse K; Guijarro D; Le Tourneau T; Conan E; Thollet A; Probst V; Trochu JN
    ESC Heart Fail; 2020 Aug; 7(4):1520-1533. PubMed ID: 32356610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational heterogeneity, modifier genes, and environmental influences contribute to phenotypic diversity of arrhythmogenic cardiomyopathy.
    Sen-Chowdhry S; Syrris P; Pantazis A; Quarta G; McKenna WJ; Chambers JC
    Circ Cardiovasc Genet; 2010 Aug; 3(4):323-30. PubMed ID: 20570917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology.
    Maron BJ; Udelson JE; Bonow RO; Nishimura RA; Ackerman MJ; Estes NAM; Cooper LT; Link MS; Maron MS
    J Am Coll Cardiol; 2015 Dec; 66(21):2362-2371. PubMed ID: 26542657
    [No Abstract]   [Full Text] [Related]  

  • 15. Left Ventricular Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC): Can We Separate ARVC From Other Arrhythmogenic Cardiomyopathies?
    Altmayer S; Nazarian S; Han Y
    J Am Heart Assoc; 2020 Dec; 9(23):e018866. PubMed ID: 33222587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization of sacubitril-valsartan for right ventricular failure in a patient with arrhythmogenic right ventricular cardiomyopathy.
    Maitz TN; Gupta R; Persin K; Sundlof DW
    Future Cardiol; 2022 Jul; 18(7):547-552. PubMed ID: 35703395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endomyocardial biopsy in right ventricular cardiomyopathy.
    Angelini A; Thiene G; Boffa GM; Calliari I; Daliento L; Valente M; Chioin R; Nava A; Volta SD; Calliaris I [corrected to Calliari I]
    Int J Cardiol; 1993 Jul; 40(3):273-82. PubMed ID: 8225662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and Clinical Aspects of Genetic Cardiomyopathies.
    Masarone D; Kaski JP; Pacileo G; Elliott PM; Bossone E; Day SM; Limongelli G
    Heart Fail Clin; 2018 Apr; 14(2):119-128. PubMed ID: 29525641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.
    Polovina M; Tschöpe C; Rosano G; Metra M; Crea F; Mullens W; Bauersachs J; Sliwa K; de Boer RA; Farmakis D; Thum T; Corrado D; Bayes-Genis A; Bozkurt B; Filippatos G; Keren A; Skouri H; Moura B; Volterrani M; Abdelhamid M; Ašanin M; Krljanac G; Tomić M; Savarese G; Adamo M; Lopatin Y; Chioncel O; Coats AJS; Seferović PM
    Eur J Heart Fail; 2023 Dec; 25(12):2144-2163. PubMed ID: 37905371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. European Society of Cardiology and the Scientific Council on Cardiomyopathies of the World Heart Federation.
    Corrado D; Fontaine G; Marcus FI; McKenna WJ; Nava A; Thiene G; Wichter T
    J Cardiovasc Electrophysiol; 2000 Jul; 11(7):827-32. PubMed ID: 10921804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.